Prospective evaluation of innovative prototypical non-contrast MRI sequences

Prospective evaluation of innovative prototypical non-contrast MRI sequences - PEPMRI

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00023805

Enrollment

500

Registered

2020-12-11

Start date

2020-08-24

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer liver cancer D13.6 C22 D26.9 C20 C55 D13

Interventions

Group 1: intraindividual comparison of image quality, increased duration of the examination

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients undergoing one of the following examinations: Abdominal MRI of - liver - rectum - pancreas - female pelvis - prostate MRI of the breast Informed Consent

Exclusion criteria

Exclusion criteria: - general MRI contraindications (devices (e.g. certain pacemakers), pregnancy, claustrophobia) - severely reduced general condition - other reasons to keep examination short - age < 18 years - no availability of scan time within the clinical program - pregnancy - loss of decision making capacity

Design outcomes

Primary

Measure	Time frame
Possible superiority or non-inferiority of non-contrast MRI sequences without use of ionizing radiation in comparison to the current clinical routine protocol workflow improvements by application of innovative AI algorithms	—

Secondary

Measure	Time frame
reduced duration of image acquistion through compressed-sensing and k-space based deep learning algorithms, cost reduction	—

Countries

Switzerland

Contacts

Public ContactAnna Landsmann

Kantonsspital Baden Radiologie

anna.landsmann@ksb.ch0041564861863

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026